Skip to main content

Together we are beating cancer

Donate now

Interview

Showing 12 out of 48 results
Ben Hood

We caught up with Ben Hood to find out how research nurses are evolving and the challenges they face…   We caught up with Ben Hood to find out how research nurses are evolving and the challenges they face…  

by Phil Prime | Interview | 17 January 2024

17 January 2024

Dr Matt Hoare explores the cancerisation field effect in liver disease and thinks cancer researchers need to pay attention to the increasing incidence of metabolic disorders… Dr Matt Hoare explores the cancerisation field effect in liver disease and thinks cancer researchers need to pay attention to the increasing incidence of metabolic disorders…

by Phil Prime | Interview | 3 October 2023

3 October 2023

Could a shift in the way you publish your work really improve research integrity, reproducibility and quality? Could a shift in the way you publish your work really improve research integrity, reproducibility and quality?

by Phil Prime | Interview | 27 September 2023

27 September 2023

We catch up with Abena Amponsah, one of the first students enrolled on to our Black Leaders in Cancer PhD Scholarship Programme, to talk about the beginning of her academic journey We catch up with Abena Amponsah, one of the first students enrolled on to our Black Leaders in Cancer PhD Scholarship Programme, to talk about the beginning of her academic journey

by Phil Prime | Interview | 20 July 2023

20 July 2023

This entry is part 8 of 8 in the series Diversity in research
  • For Researchers

Harnessing the power of CD3

Revolutionising our understanding of cancer risk using a huge variety of data to advance early detection of the disease – it sounds as ambitious as it is exciting, but is it possible? We caught up with Professor Antonis Antoniou to find out... Revolutionising our understanding of cancer risk using a huge variety of data to advance early detection of the disease – it sounds as ambitious as it is exciting, but is it possible? We caught up with Professor Antonis Antoniou to find out...

by Phil Prime | Interview | 30 May 2023

30 May 2023

Professor Silvia Formenti whets our appetite for all things radiotherapy. She tells us what excites her about the future of the field and why support for research is so important… Professor Silvia Formenti whets our appetite for all things radiotherapy. She tells us what excites her about the future of the field and why support for research is so important…

by Phil Prime | Interview | 26 May 2023

26 May 2023

Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation. Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation.

by Tim Bodicoat | Interview | 26 April 2023

26 April 2023

This April we come together with partners to celebrate the inaugural Teenage and Young Adult Cancer Awareness month. Caroline-May Huxley and Sandra Strauss explore the importance of shedding a light on cancer in this age group. This April we come together with partners to celebrate the inaugural Teenage and Young Adult Cancer Awareness month. Caroline-May Huxley and Sandra Strauss explore the importance of shedding a light on cancer in this age group.

by Phil Prime | Interview | 5 April 2023

5 April 2023

Left to right: Emma Colliver, Dr William Hill and Dr Emilia Lim

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today.  We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

by Jacob Smith | Interview | 13 December 2022

13 December 2022

Simon-Boulton-and-Kairbaan-Hodivala-Dilke

We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs. We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs.

by Phil Prime | Interview | 22 November 2022

22 November 2022